You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 億勝生物科技(1061.HK)大漲逾14%創2年新高 月內累計飆升40%
格隆匯 06-24 15:40
格隆匯6月24日丨億勝生物科技(1061.HK)漲幅擴大至超14%,報7.46港元創2年新高價,成交額放大至5540萬港元亦創階段新高,總市值達43億港元。該股本月初開始啟動,截至目前累計漲幅高達40%。公司此前披露1-4月收入同比大幅增長242.2%,自主創新和接連收購的優質產品,吸引着資金不斷的加碼。業內人士稱,作為港股優質的上市醫藥股公司,多年來的辛勤經營也逐漸獲得了資本市場的認可。有機構分析指出,羅氏投的ACIU亞洲合作伙伴是億勝生物科技,之前停了,日前biogen獲批後他們也會重啟。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account